Market Snapshot
S&P Futures
4,146
Dow Futures
32,829
Nasdaq Futures
13,193.75
Agios Pharmaceuticals, Inc. (AGIO) stock declined over -1.21% intraday to trade at $29.38 a share on NASDAQ. The stock opened with a gain of 5.61% at $29.5 and touched an intraday high of $29.53, falling -1.21% against the last close of $29.74. The stock went to a low of $28.265 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-08-08 | $29.5 | $29.53 | $28.265 | $29.38 | 641,405 |
2022-08-05 | $27.82 | $30.05 | $27.09 | $29.74 | 1,056,400 |
2022-08-04 | $25.57 | $28.62 | $25.57 | $28.61 | 1,180,000 |
2022-08-03 | $23.35 | $24.96 | $23.35 | $24.95 | 684,100 |
2022-08-02 | $21.13 | $23.26 | $21 | $22.95 | 902,400 |
2022-08-01 | $21.24 | $21.79 | $21.01 | $21.29 | 423,400 |
2022-07-29 | $21.38 | $21.61 | $20.9 | $21.57 | 789,600 |
2022-07-28 | $21.5 | $21.86 | $20.89 | $21.52 | 564,600 |
2022-07-27 | $20.59 | $21.7 | $20.41 | $21.62 | 724,200 |
2022-07-26 | $19.96 | $20.33 | $19.43 | $19.51 | 545,900 |
Employees-
Beta1.26
Sales or Revenue832 Thousands
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryBiotechnology
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stock price is $29.38 as of the last check on Monday, August 8. During the trading session, AGIO stock reached the peak price of $29.53 while $28.265 was the lowest point it dropped to.
The NASDAQ listed AGIO is part of Biotechnology industry that operates in the broader Health Care sector. Agios Pharmaceuticals, Inc. , a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology.
Dr. Bruce Car Ph.D.
Chief Scientific Officer
Dr. Clive Patience Ph.D.
Chief Technical Operations Officer
Ms. Kendra Adams
VP of External Communications & Investor Relations
Dr. Jacqualyn A. Fouse Ph.D.
CEO & Director
AGIO stock traded closed the last session at $29.38, which is -$0.35999999999999943 or -1.21% lower than its previous close of $29.74. AGIO's current trading price is 75.4% lower than its 52-week high of $50.98 where as its distance from 52-week low of 16.75% is -42.37%.
Number of AGIO employees currently stands at -. AGIO operates from 88 Sidney Street, 2nd Floor, Cambridge, MA 02139-4169, United States.
Official Webiste of $AGIO is: https://www.agios.com
AGIO could be contacted at AGIO operates from 88 Sidney Street, 2nd Floor, Cambridge, MA 02139-4169, United States, or at phone #617 649 8600 and can also be accessed through its website.
AGIO stock volume for the day was 672,586 shares while in the previous session number of AGIO shares traded was 641,405 . The average number of AGIO shares traded daily for last 3 months was 729.1 Thousands.
The percentage change in AGIO stock occurred in the recent session was -1.21% while the dollar amount for the price change in AGIO stock was -$0.35999999999999943.
In the recent session, the day high for AGIO stock was $29.53 while the low for AGIO stock touched on the day was $28.265.
The market value of AGIO currently stands at 1.55 Billion with its latest stock price at $29.38 and 54.8 Million of its shares outstanding.